相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PACE: Analysis of acute toxicity in PACE-B, an international phase Ill randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).
Nicholas John Van As et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events
F. Hall et al.
QUALITY OF LIFE RESEARCH (2019)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer
Soumon Rudra et al.
CANCER MEDICINE (2019)
Favorable 10-year outcomes of image-guided intensity-modulated radiotherapy combined with long-term androgen deprivation for Japanese patients with nonmetastatic prostate cancer
Natsuo Tonnita et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer
B. A. Jereczek-Fossa et al.
MEDICAL ONCOLOGY (2019)
High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience
Beatrice Detti et al.
RADIOLOGIA MEDICA (2019)
Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer
Nancy El-Bared et al.
PRACTICAL RADIATION ONCOLOGY (2019)
Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer
A. T. Zemplenyi et al.
EUROPEAN JOURNAL OF CANCER CARE (2018)
Give me five ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach
Giulia Marvaso et al.
MEDICAL ONCOLOGY (2018)
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
Lauren Henke et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial
Lynda Constable et al.
TRIALS (2018)
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
David Cameron et al.
GLOBAL HEALTH ACTION (2018)
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
Hideya Yamazaki et al.
CANCERS (2018)
Time-Driven Activity Based Costing of CT-Guided vs. MR-Guided SBRT in Patients with Unresectable Hepatocellular Carcinoma
N. R. Parikh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Volumetric image-guided conformal radiotherapy for localized prostate cancer: Analysis of dosimetric and clinical factors affecting acute and late toxicity
Gianluca Ingrosso et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2018)
Prospective In Silico Study of the Feasibility and Dosimetric Advantages of MRI-Guided Dose Adaptation for Human Papillomavirus Positive Oropharyngeal Cancer Patients Compared With Standard IMRT
A. S. R. Mohamed et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Acute toxicity and its dosimetric correlates for high-risk prostate cancer treated with moderately hypofractionated radiotherapy
Moses Arunsingh et al.
MEDICAL DOSIMETRY (2017)
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy
Hamid Raziee et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven. activity-based analysis
Jacob Van Dyk et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis
Gianluca Ingrosso et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2017)
Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer
Allen M. Chen et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Early toxicity of hypofractionated radiotherapy for prostate cancer
Pavel Krupa et al.
BIOMEDICAL PAPERS-OLOMOUC (2016)
Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer
Kentaro Ishii et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
N. G. Di Muzio et al.
CLINICAL ONCOLOGY (2016)
Intrafraction Organ Motion Tracking With Real-Time MRI-Guided Radiation Therapy for Head and Neck Cancer
J. C. Rwigema et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Re: Infections after Fiducial Marker Implantation for Prostate Radiotherapy: Are we Underestimating the Risks?
J. Loh et al.
JOURNAL OF UROLOGY (2016)
MRI-guided prostate adaptive radiotherapy - A systematic review
A. J. McPartlin et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications
Ryan C. Hutchinson et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Epidemiology of Prostate Cancer
Muhammad Naeem Bashir
Asian Pacific Journal of Cancer Prevention (2015)
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy
Joseph R. Evans et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease
H. Jervoise N. Andreyev et al.
FRONTLINE GASTROENTEROLOGY (2015)
Comparison of Image-guided Radiotherapy Technologies for Prostate Cancer
Satya Das et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients
Ovidiu Marina et al.
BRACHYTHERAPY (2014)
Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity
James B. Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
Sasa Mutic et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future
Patrick Kupelian et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Moderately hypofractionated radiotherapy for localized prostate cancer Long-term outcome using IMRT and volumetric IGRT
M. Guckenberger et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Cost of prostate image-guided radiation therapy: Results of a randomized trial
Lionel Perrier et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis
T. N. Showalter et al.
ANNALS OF ONCOLOGY (2012)
Current Treatment of Lower Gastrointestinal Hemorrhage
Tal Raphaeli et al.
Clinics in Colon and Rectal Surgery (2012)
Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer
Anju Parthan et al.
FRONTIERS IN ONCOLOGY (2012)
Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life
Maaike R. Moman et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer
Matthias Guckenberger et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Health state utilities for non small cell lung cancer
Beenish Nafees et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2008)
Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer
Jonathan C. Cheng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Factors Associated with Variation in Utility Scores among Patients with Prostate Cancer
Fumitaka Shimizu et al.
VALUE IN HEALTH (2008)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage
Wilma D. Heemsbergen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Utilities for prostate cancer health states in men aged 60 and older
ST Stewart et al.
MEDICAL CARE (2005)
A review of prostate motion with considerations for the treatment of prostate cancer
TE Byrne
MEDICAL DOSIMETRY (2005)
The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: Findings from a retrospective analysis of health plan data
DF Penson et al.
JOURNAL OF UROLOGY (2004)
A Bayesian approach to Markov modelling in cost-effectiveness analyses: application to taxane use in advanced breast cancer
NJ Cooper et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2003)
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
